-
www.ahrq.gov/evidencenow/heart-health/cholesterol/statins.html
September 01, 2018 - Strategies to Better Manage Lipids—Statin Pearls
Resource title: Strategies to Better Manage Lipids—Statin Pearls
Resource description: This slide deck and transcript of a 20-minute video with a family physician at Virginia Commonwealth University reviews current recommendations for the use of statins in lo…
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2020_CORE.PDF
January 01, 2020 - CVASC PROC WITH DRUG-ELUTING STENT WITH MCC OR 4+ ARTERIES OR STENTS 16,898 0.10%
246: PERCUTANEOUS CARDIOVASCULAR … PROCEDURES W MCC 18,619 0.11%
270: OTHER MAJOR CARDIOVASCULAR PROCEDURES WITH MCC 6,785 0.04%
271: … OTHER MAJOR CARDIOVASCULAR PROCEDURES W CC 16,309 0.10%
271: OTHER MAJOR CARDIOVASCULAR PROCEDURES … WITH CC 5,641 0.03%
272: OTHER MAJOR CARDIOVASCULAR PROCEDURES W/O CC/MCC 5,569 0.03%
272: OTHER MAJOR … CARDIOVASCULAR PROCEDURES WITHOUT CC/MCC 2,141 0.01%
273: PERCUTANEOUS AND OTHER INTRACARDIAC PROCEDURES
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2020_Core_Weighted.PDF
January 01, 2020 - CVASC PROC WITH DRUG-ELUTING STENT WITH MCC OR 4+ ARTERIES OR STENTS 30,412 0.09%
246: PERCUTANEOUS CARDIOVASCULAR … PROCEDURES W MCC 34,738 0.11%
270: OTHER MAJOR CARDIOVASCULAR PROCEDURES WITH MCC 12,644 0.04%
271 … : OTHER MAJOR CARDIOVASCULAR PROCEDURES W CC 30,265 0.09%
271: OTHER MAJOR CARDIOVASCULAR PROCEDURES … WITH CC 10,591 0.03%
272: OTHER MAJOR CARDIOVASCULAR PROCEDURES W/O CC/MCC 10,289 0.03%
272: OTHER … MAJOR CARDIOVASCULAR PROCEDURES WITHOUT CC/MCC 3,964 0.01%
273: PERCUTANEOUS AND OTHER INTRACARDIAC
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/nonopioid-pharm-chronic-pain-protocol.pdf
February 01, 2019 - Specific adverse events for each drug class, such as
gastrointestinal events, cardiovascular events, … • Key specific adverse events, according to
drug class, such as gastrointestinal and
cardiovascular
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/gaps-pain-management.pdf
January 01, 2023 - Studies evaluating the efficacy of acute
treatments in specific populations, including
those with cardiovascular … NSAIDs have increased risk of serious
gastrointestinal, liver dysfunction, and
cardiovascular adverse
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypothyroidism-hyperthyroidism-screening-treatment_disposition-comments.pdf
February 01, 2012 - current
wording : “Epidemiologic data suggest that
subclinical hypothyroidism is associated with
cardiovascular … Omission of data on heart failure is problematic. we feel the term “cardiovascular” includes
both, CAD
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs018236-ziemer-final-report-2012.pdf
January 01, 2012 - obtain the essential information to make informed therapeutic decisions for
diabetes and its major cardiovascular … Nine-year trends in achievement of risk
factor goals in the US and European outpatients with cardiovascular
-
psnet.ahrq.gov/node/72739/psn-pdf
February 10, 2021 - Editor’s Choice-Biomarkers of acute cardiovascular and
pulmonary diseases. … European Heart Journal: Acute Cardiovascular Care. 2015;5(5):416-433.
-
digital.ahrq.gov/sites/default/files/docs/resource/B7_Archives_Pohl_HS17034_1013_1.pdf
February 14, 2011 - Denominator Numerator
% of office visits for a
patient with
hypertension in which
the HTN
("cardiovascular … Use of Coding Expert
se the cardiovascular form is an ineffective and underused form for HTN
Measure
-
www.ahrq.gov/cpi/centers/ockt/kt/tools/impuspstf/impuspstf2.html
June 01, 2022 - Risk assessment: Blood pressure is an important predictor of complications of cardiovascular disease … Screening and Behavioral Counseling Interventions
X
X
X
Aspirin for the Prevention of Cardiovascular
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety-2/vol4/Advances-Masica_112.pdf
November 30, 2010 - Likewise, beta-blockers and lipid-
lowering drugs are apparently underused in elderly patients with cardiovascular … Benefits of
pravastatin on cardiovascular events and mortality in
older patients with coronary heart
-
www.ahrq.gov/sites/default/files/wysiwyg/evidencenow/tools-and-materials/chcanys-qi-primer.pdf
August 01, 2017 - American, and 13% Asian).
1
Heart disease is the primary
cause of death in the city and prevalence of cardiovascular … Overall Project Aim:
The overarching goal of this project is to ensure FQHCs have the latest evidence on cardiovascular
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication-september-2014
September 09, 2014 - investigate whether preeclampsia prevention with low-dose aspirin affects women's long-term risk for cardiovascular … Awad IA, Chireau MV, Fedder WN, Furie KL, et al; American Heart Association Stroke Council; Council on Cardiovascular
-
www.ahrq.gov/healthsystemsresearch/hspc-research-study/impacts.html
June 01, 2020 - identified the Systolic Blood Pressure Intervention Trial (NHLBI, undated) and the Action to Control Cardiovascular … Risk in Diabetes studies ( Action to Control Cardiovascular Risk in Diabetes, 2019 ) as examples of
-
psnet.ahrq.gov/web-mm/delay-appropriate-diagnosis-and-treatment-leading-death-pulmonary-embolism
December 31, 2024 - Editor’s Choice-Biomarkers of acute cardiovascular and pulmonary diseases. … European Heart Journal: Acute Cardiovascular Care . 2015;5(5):416-433. doi:10.1177/2048872616652309.
-
hcup-us.ahrq.gov/reports/statbriefs/sb185-Hospital-Intensive-Care-Units-2011.jsp
December 01, 2014 - hemorrhage or cerebral infarction with MCC
68,604
64.6
50,000
27.1
247 Percutaneous cardiovascular … with complication or comorbidity to a low of 10.3 percent of total hospital charges for percutaneous cardiovascular
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-pain-opioid-treatment_research-protocol.pdf
December 19, 2013 - gastrointestinal-related harms, falls, fractures, motor vehicle
accidents, endocrinological harms, infections, cardiovascular … gastrointestinal, falls,
fractures, motor vehicle accidents, endocrinological harms, infections,
cardiovascular
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/research-protocol-osteoporosis_2.pdf
October 05, 2018 - Progestin
combination
products
Multiple* Oral,
transdermal,
transvaginal
Daily 1-3 yr >3 yr Cardiovascular … yr >3 yr
Anti-sclerostin
monoclonal
antibody
Romosozumab† SC Monthly 1 yr Not
used
>1 yr
Cardiovascular … 16
CI confidence intervals
CKD chronic kidney disease
CTX C-terminal telopeptide
CVD cardiovascular
-
digital.ahrq.gov/sites/default/files/docs/citation/r21hs024117-leung-final-report-2018.pdf
January 01, 2018 - long-term consequences
as it not only leads to negative health outcomes, such as type 2 diabetes and cardiovascular … Childhood obesity and adult
cardiovascular disease risk factors: a systematic review with meta-analysis … Sugar Sweetened Beverages, Obesity,
Type 2 Diabetes and Cardiovascular Disease risk.
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2014chartbooks/hispanichealth/2014nhqdr-hispanichealth-pt4.pptx
January 01, 2014 - New Mexico and Texas are weak in care for cardiovascular disease. … Arizona is also strong in care for cardiovascular disease.
7
Quality Scores in Border States by Type … Interest
Cancers: Any Dx in CCS 24 (breast), 26 (cervix), 29 (prostate), or in range 140.x-149.x (oral)
Cardiovascular